公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

记录的 EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA取消

317 记录

产品持有公司班级有效性
ANTI-CLAMIDIA MIF IGA10338930094EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV19/05/2034
ANTI-CLAMIDIA MIF IGG10338930091EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV31/03/2034
ANTI-HSV 1/2 IGM10338930090EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII24/03/2034
Anti-Dengue vírus NS1 tipo 1-4 ELISA IgG10338930290EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII26/06/2033
Anti-Hanta Virus Pool 2 America ELISA (IgG)10338930257EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII23/08/2031
Anti-Hanta Virus Pool 2 America ELISA (IgM)10338930258EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII23/08/2031
Anti-SARS-CoV-2 QuantiVac ELISA (IgG)10338930247EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII03/05/2031
EUROArray STI 1110338930233EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV09/11/2030
Anti-SARS-CoV-2-NCP ELISA (IgG)10338930229EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII28/05/2030
Anti-SARS-CoV-2 ELISA IgA10338930226EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII03/04/2030
Anti-SARS-CoV-2 IgG ELISA10338930227EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII03/04/2030
Anti-Hepatite E (HEV) IgM10338930223EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII29/07/2029
Anti-Mayaro vírus IgM10338930199EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII28/01/2029
Anti-Mayaro vírus IgG10338930200EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII28/01/2029
Anti-Schistosoma mansoni IgG10338930196EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII29/10/2028
T-SPOT® TB10338930301EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII17/09/2028
EUROArray HLA-DQ2/DQ8 Direto81148560071EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII09/07/2028
EUROArray HLA-DQ2/DQ8-h Direto81148560072EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII09/07/2028
Anti-Schistosoma mansoni IgM81148560070EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII25/06/2028
Anti-Dengue tipo 1-4 IgM81148560068EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII18/12/2027
Treponema pallidum no líquor IgG81148560066EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV11/12/2027
IF: Leishmania donovani IgG81148560064EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII25/09/2027
IF: Leishmania donovani IgM81148560065EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII25/09/2027
Treponema pallidum Screen81148560046EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIV27/03/2027
EUROArray HPV81148560043EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDAIII13/03/2027

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家